Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers find stem cells in colorectal tumors

05.06.2007
Researchers at the Stanford University School of Medicine have identified the cancer stem cells that propagate tumors in colon and rectal cancer, a discovery that could lead to improved treatment of this deadly cancer.

These are the latest class of cancer stem cells tracked down by a large, interdisciplinary group of researchers led by Michael Clarke, MD. The discovery is reported in the June 4 advance online edition of the Proceedings of the National Academy of Sciences.

"This work will enable us to better understand how to identify these cells, and to do molecular studies to find potential new therapies," said Clarke, the senior author of the paper and the Karel H. and Avice N. Beekhuis Professor in Cancer Biology.

Clarke was the first to find cancer stem cells in a solid tumor - in this case, breast cancer - in 2003 while working at the University of Michigan. Since coming to Stanford in 2005, he joined existing efforts that have resulted in finding cancer stem cells in head and neck, pancreatic and now colorectal tumors.

These stem cells act like a spring at the source of a creek, constantly dividing to produce new tumor cells. Although the other tumor cells can divide and cause damage through their sheer bulk, they are shorter lived and can't maintain the tumor's growth. The cancer stem cells are also likely to be responsible when tumors spread to distant sites.

Identifying new cancer stem cells has been a major push within Stanford's Institute for Stem Cell Biology and Regenerative Medicine, where Clarke serves as associate director. Irving Weissman, MD, director of the institute, said he hopes Stanford researchers will develop cancer therapies that specifically kill these cancer stem cells, eradicating the cancer entirely. Current therapies may kill the bulk of the tumor cells, but if any cancer stem cells remain the tumor will resurface or spread.

"We have brought together a team of scientists and clinicians who will help find the weak points in cancer, devise new immune and molecular diagnostics and therapeutics, test them in mice that carry the cancer stem cells and, hopefully, in a few years begin to test them in our patients," Weissman said.

The colorectal cancer stem cells highlight the importance of a protein that is a familiar face to this group of cancer researchers. A protein called CD44 that has already been found dotting the surface of both breast and head and neck cancer stem cells also turns up on the colorectal cancer stem cells. To Piero Dalerba, MD, postdoctoral scholar and first author of the paper, that finding could simply reflect the fact that all of those tumors arise from similar tissue. It could also mean that a similar therapy could target all three cell types.

Dalerba also found a novel protein on the colorectal cancer stem cells, called CD166, that had not previously been associated with cancer stem cells. "This is one of the major novelties of this paper," he said. This protein could be a unique target for identifying and treating colorectal cancers.

Colon and rectal cancers are the second-most common cause of cancer-related deaths in the United States, killing more than 50,000 people each year. The tumors often go undetected until they are at a later stage and are difficult to treat. Treatment can include chemotherapy, radiation or surgery. However, Andrew Shelton, MD, assistant professor of surgery who treats colon cancer patients and participated in this study, said it's often hard to know which patients will respond best to the different treatment options.

Shelton said that grouping patients according to the treatments most likely to work for them is one possible future benefit of finding the cancer stem cells. In breast cancer, Clarke and another team of researchers recently found a group of genes that show unique patterns of being turned on or off in people who either do or don't respond well to treatment. The group hopes to do similar work with the colorectal cancer stem cells as a first step in identifying patients who may need more aggressive treatment.

Amy Adams | EurekAlert!
Further information:
http://mednews.stanford.edu

Further reports about: Protein Stem Treatment colorectal colorectal cancer

More articles from Life Sciences:

nachricht Climate Impact Research in Hannover: Small Plants against Large Waves
17.08.2018 | Leibniz Universität Hannover

nachricht First transcription atlas of all wheat genes expands prospects for research and cultivation
17.08.2018 | Leibniz-Institut für Pflanzengenetik und Kulturpflanzenforschung

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Color effects from transparent 3D-printed nanostructures

New design tool automatically creates nanostructure 3D-print templates for user-given colors
Scientists present work at prestigious SIGGRAPH conference

Most of the objects we see are colored by pigments, but using pigments has disadvantages: such colors can fade, industrial pigments are often toxic, and...

Im Focus: Unraveling the nature of 'whistlers' from space in the lab

A new study sheds light on how ultralow frequency radio waves and plasmas interact

Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...

Im Focus: New interactive machine learning tool makes car designs more aerodynamic

Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.

When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

Im Focus: The “TRiC” to folding actin

Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.

Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

LaserForum 2018 deals with 3D production of components

17.08.2018 | Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

 
Latest News

Smallest transistor worldwide switches current with a single atom in solid electrolyte

17.08.2018 | Physics and Astronomy

Robots as Tools and Partners in Rehabilitation

17.08.2018 | Information Technology

Climate Impact Research in Hannover: Small Plants against Large Waves

17.08.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>